SCHEMBL18573222

SCHEMBL18573222

CCCCCc1ccc(-c2ccc(C(=O)Cl)cn2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 8/20 0.70
▸ SMN1; SMN2 Q16637 7/20 0.70
▸ NPC1 O15118 7/20 0.70
▸ NFKB1 P19838 2/20 0.70
▸ NFKB2 Q00653 2/20 0.70
▸ RELA Q04206 2/20 0.70
▸ MAPT P10636 4/20 0.59
▸ STAT3 P40763 1/20 0.59
▸ ATM Q13315 1/20 0.59
▸ ALDH1A1 P00352 3/20 0.56
▸ KDM4E B2RXH2 2/20 0.56
▸ HPGD P15428 2/20 0.56
▸ CASP3 P42574 2/20 0.56
▸ SENP8 Q96LD8 2/20 0.56
▸ SENP7 Q9BQF6 2/20 0.56
▸ SENP6 Q9GZR1 2/20 0.56
▸ TP53 P04637 1/20 0.56
▸ RARB P10826 6/20 0.55
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ MEN1 O00255 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10661558 0.90 RAB9A (0.74) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL10557313 0.88 RAB9A (0.71) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL9734731 0.86 SMN1; SMN2 (0.82) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL11612452 0.85 ALDH1A1 (0.62) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL9745034 0.83 MAPT (0.65) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL11611675 0.83 MAPT (0.65) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL9745010 0.83 MAPT (0.65) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL30175860 0.83 RAB9A (0.65) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL11612451 0.83 MAPT (0.65) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL11554077 0.82 RARB (0.73) MAPTALDH1A1RARBMEN1RARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322826-A1 METAL COMPLEXES UDC IRELAND LIMITED (IE) 2023-10-12 — — US disclosed
US-11713332-B2 Metal complexes MERCK PATENT GMBH (DE) 2023-08-01 — — US disclosed
WO-2017032439-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-03-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713332-B2 Metal complexes AP1M1, SOD1, AP3M1 RAB9A 2231/4885SMN1; SMN2 3848/4885NPC1 3533/4885
US-20230322826-A1 METAL COMPLEXES AP1M1, SOD1, AP3M1 RAB9A 2231/4885SMN1; SMN2 3848/4885NPC1 3533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback